Neopharm

Neopharm operates as a pharmacy chain in Russia, providing retail pharmaceutical services that include dispensing prescription medications, over‑the‑counter products, medication reservation systems, loyalty programs, and point‑of‑sale transactions. Its services are delivered through physical storefronts where customers can obtain medicines and access digital tools for refill requests and reward tracking. The organisation serves individual consumers seeking healthcare products in urban markets, primarily within the Russian Federation. Its business model integrates traditional pharmacy retail with digital platforms to manage prescriptions and customer engagement. By offering both in‑store and online functionalities, Neopharm aims to streamline medication access for its clientele. The chain’s core activity revolves around the distribution and sale of pharmaceutical goods to the public.

Neopharm is described as a major Russian pharmacy chain with headquarters located in Russia. It operates over 110 pharmacies in the cities of Moscow and Saint Petersburg, representing a significant presence in those metropolitan areas. The July 2025 cyberattack that forced the suspension of its operations affected all of these locations, disrupting prescription access, medication reservations, loyalty programs, and point‑of‑sale systems. When combined with a similar outage at its rival Stolichki, the incident contributed to the temporary closure of more than 1,100 pharmacy outlets across central Russia. This scale illustrates the chain’s considerable footprint within the national pharmacy sector. The disruption highlighted how integral Neopharm’s digital infrastructure is to its daily retail functions.

Neopharm’s distinguishing attributes include its reliance on integrated digital systems for prescription management, reservation services, loyalty programs, and point‑of‑sale operations, which are central to its customer service model. The chain’s broad impact on pharmacy availability during the outage demonstrates its significant market presence. Its specialization lies in combining traditional pharmaceutical retail with digital customer engagement tools, a competency that was directly targeted in the 2025 cyber incident. The event placed Neopharm among a wave of cyberattacks that have recently struck Russian enterprises, underscoring its visibility and importance within the country’s critical retail healthcare infrastructure. These factors collectively define Neopharm’s role as a digitally enabled pharmacy chain operating at a substantial scale within Russia.